M
Medicus Pharma Ltd. (MDCX)
NCM – Real Time Price. Currency in USD
0.45
-0.02 (-3.37%)
At close: Mar 27, 2026, 4:00 PM EDT
0.44
-0.01 (-2.58%)
After-hours: Mar 27, 2026, 7:45 PM EDT
Get all premium features to the best stock analysis tool
NCM – Real Time Price. Currency in USD
0.45
-0.02 (-3.37%)
At close: Mar 27, 2026, 4:00 PM EDT
0.44
-0.01 (-2.58%)
After-hours: Mar 27, 2026, 7:45 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 0.92 | 1.97 | 6.0 | |
| Quick ratio | 0.92 | 1.37 | 6.0 | |
| Debt to Equity | N/A | -7.73 | 1.0 | |
| Debt to Assets | 0.71 | 0.29 | 3.0 | |
| Interest coverage | N/A | 36.83 | 1.0 | |
| Weighted average score | 3.4 | |||
| METRIC | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A |
| Operating Income | -752K | -4M | -8M | -15M |
| Net Income | -1M | -4M | -8M | -21M |
| EBITDA | -752K | -4M | -8M | -13M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | 67.05 | 1.0 | |
| Operating margin % | N/A | 0.14 | 1.0 | |
| Net margin % | N/A | 9.34 | 1.0 | |
| EBITDA margin % | N/A | 19.90 | 1.0 | |
| Cash flow margin % | N/A | 21.79 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 50 | 5.5 |
| Next quarter | N/A | 67.82 | 5.5 |
| Current year | N/A | -56.47 | 1.0 |
| Next year | N/A | 72.18 | 5.5 |
| Weighted average score | 4.4 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -160.19 | -160.46 | -22.13 | 3.3 |
| Y/Y | 999 | -594.61 | -261.28 | -116.59 | 3.3 |
| 3y average | N/A | N/A | N/A | N/A | 1.0 |
| 5y average | N/A | N/A | N/A | N/A | 1.0 |
| Weighted average score | 2.2 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $6.2M significantly exceed its total debt $5.1M, ensuring strong financial flexibility
Total current assets $7.0M are just enough to cover Total current liabilities $7.7M, indicating tight liquidity
Debt-to-equity ratio (-8.8) is well below the industry average (-7.7), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$4.9M limits the company's ability to reinvest or pay down debt